Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 17, 2023 | Horse | Horse (unknown) | MSK | Generalised allergic reaction NOS | Outcome Unknown |
| Nov 16, 2023 | Horse | Thoroughbred | MSK | Anorexia; Lethargy (see also Central nervous system depression in Neurological) | Recovered/Normal |
| Nov 16, 2023 | Horse | Warmblood (unspecified) | MSK | Comedo/blackhead | Ongoing |
| Nov 16, 2023 | Horse | Quarter Horse, Horse (unknown) | MSK | Dull; Decreased appetite | Outcome Unknown |
| Nov 14, 2023 | Horse | Horse (unknown) | MSK | Diarrhoea | Outcome Unknown |
| Nov 14, 2023 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Nov 14, 2023 | Horse | Horse (other) | MSK | Lack of efficacy - NOS | Ongoing |
| Nov 14, 2023 | Horse | Pony (unspecified) | MSK | Gastric ulcer; Lack of efficacy - NOS | Outcome Unknown |
| Nov 13, 2023 | Horse | Thoroughbred | MSK | Pruritus; Pale mucous membrane; Lying down; Uncomfortable | Ongoing |
| Nov 13, 2023 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Nov 13, 2023 | Horse | Thoroughbred | MSK | Pruritus; Pale mucous membrane; Lying down; Uncomfortable; Discomfort NOS; An... | Ongoing |
| Nov 12, 2023 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Ongoing |
| Nov 10, 2023 | Horse | Quarter Horse | MSK | Hives (see also Skin) | Recovered/Normal |
| Nov 9, 2023 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Nov 9, 2023 | Horse | Quarter Horse | MSK | Behavioural disorder NOS | Outcome Unknown |
| Nov 9, 2023 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Ongoing |
| Nov 8, 2023 | Horse | Thoroughbred | MSK | Enlarged lymph node (localised); Fever; Neutrophilia; Decreased red blood cel... | Ongoing |
| Nov 8, 2023 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Nov 7, 2023 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Nov 7, 2023 | Horse | Saddlebred - American | MSK | Lack of efficacy - NOS | Ongoing |
| Nov 7, 2023 | Horse | Arab | MSK | Behavioural disorder NOS | Outcome Unknown |
| Nov 6, 2023 | Horse | Horse (other) | MSK | Application site irritation; Oral ulceration | Recovered/Normal; Outcome Unknown |
| Nov 6, 2023 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Nov 6, 2023 | Horse | Arab | MSK | Ataxia; Anorexia | Outcome Unknown |
| Nov 6, 2023 | Horse | Horse (unknown) | MSK | Aneurism | Outcome Unknown |
| Nov 5, 2023 | Horse | Quarter Horse | MSK | Not drinking; Discoloured urine; Injection site hair loss; Rolling; Drooling;... | Died |
| Nov 3, 2023 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Nov 3, 2023 | Horse | Friesian | MSK | Seizure NOS; Death; Medication error NOS | Died |
| Nov 3, 2023 | Horse | Horse (unknown) | MSK | Behavioural disorder NOS; Decreased appetite; Increased bowel movements (freq... | Outcome Unknown |
| Nov 3, 2023 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Nov 3, 2023 | Horse | Arab | MSK | Ataxia; Pale mucous membrane; Gut sounds decreased; Other abnormal test resul... | Recovered/Normal |
| Nov 2, 2023 | Horse | Warmblood (unspecified) | MSK | Injection site swelling | Recovered/Normal |
| Nov 2, 2023 | Horse | Horse (unknown) | MSK | Death; Colic | Died |
| Nov 2, 2023 | Horse | Quarter Horse | MSK | Application site oedema; Face and neck swelling (see also Skin); Swollen gum | Recovered/Normal |
| Nov 2, 2023 | Horse | Horse (unknown) | MSK | Injection site oedema | Recovered/Normal |
| Nov 2, 2023 | Horse | Unknown | MSK | Joint swelling | Recovered/Normal |
| Nov 2, 2023 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Nov 1, 2023 | Horse | Horse (unknown) | MSK | Death | Died |
| Nov 1, 2023 | Horse | Horse (unknown) | MSK | Behavioural disorder NOS | Outcome Unknown |
| Nov 1, 2023 | Horse | Percheron, Pura Raza Españo... | MSK | Digestive tract disorder NOS | Outcome Unknown |
| Nov 1, 2023 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Nov 1, 2023 | Horse | Thoroughbred | MSK | Injection site swelling | Outcome Unknown |
| Oct 31, 2023 | Horse | Rocky Mountain Horse | MSK | Gastric ulcer | Recovered/Normal |
| Oct 31, 2023 | Horse | Belgian Draft, also called ... | MSK | Anaphylaxis; Ptyalism; Tachypnoea; Cyanotic mucous membranes; Heavy sweating;... | Recovered/Normal |
| Oct 31, 2023 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Oct 30, 2023 | Horse | Oldenburg | MSK | Lack of efficacy - NOS | Ongoing |
| Oct 30, 2023 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Oct 28, 2023 | Horse | Arab | MSK | Partial anorexia; Diarrhoea | Recovered/Normal |
| Oct 28, 2023 | Horse | Horse (other) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Oct 27, 2023 | Horse | Warmblood - Dutch | MSK | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy; Underdose | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.